RGC
Regencell BioscienceยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
RGC Profile
Regencell Bioscience Holdings Limited
An early-stage bioscience company that focuses on the treatment of neurocognitive disorders and degenerations
Pharmaceutical
10/30/2014
07/16/2021
NASDAQ Stock Exchange
10
06-30
Common stock
9/F Chinachem Leighton Plaza, 29 Leighton Road, Causeway Bay, Hong Kong
--
Regencell Bioscience Holdings Limited is a holding company incorporated in the Cayman Islands on October 30, 2014. They are an early stage bioscience company dedicated to the research, development and commercialization of traditional Chinese medicine for the treatment of neurocognitive disorders and degeneration, especially ADHD and ASD. Their goal is to improve the lives of ADHD and ASD patients, their families and caregivers, and to become the market leader for the best ADHD and ASD treatments in the world.
